Follow
Elizabeth Krakow
Elizabeth Krakow
Attending Physician, Fred Hutchinson Cancer Research Center
Verified email at frasch.ca
Title
Cited by
Cited by
Year
Success of immunosuppressive treatments in patients with chronic graft-versus-host disease
SJ Lee, TD Nguyen, L Onstad, M Bar, EF Krakow, RB Salit, PA Carpenter, ...
Biology of Blood and Marrow Transplantation 24 (3), 555-562, 2018
432018
Tools for the precision medicine era: how to develop highly personalized treatment recommendations from cohort and registry data using Q-learning
EF Krakow, M Hemmer, T Wang, B Logan, M Arora, S Spellman, ...
American journal of epidemiology 186 (2), 160-172, 2017
352017
HLA-mismatched microtransplant in older patients newly diagnosed with acute myeloid leukemia: results from the microtransplantation interest group
M Guo, NJ Chao, JY Li, DA Rizzieri, QY Sun, A Mohrbacher, EF Krakow, ...
JAMA oncology 4 (1), 54-62, 2018
322018
Quality of life of caregivers of hematopoietic cell transplant recipients
K Jamani, LE Onstad, M Bar, PA Carpenter, EF Krakow, RB Salit, ...
Biology of Blood and Marrow Transplantation 24 (11), 2271-2276, 2018
262018
Cardiac surgery in patients with haemophilia B: a case report and review of the literature
EF Krakow, I Walker, A Lamy, JAM Anderson
Haemophilia 15 (1), 108-113, 2009
252009
Rates and risk factors for post-traumatic stress disorder symptomatology among adult hematopoietic cell transplant recipients and their informal caregivers
J Liang, SJ Lee, BE Storer, BE Shaw, EJ Chow, ME Flowers, EF Krakow, ...
Biology of Blood and Marrow Transplantation 25 (1), 145-150, 2019
232019
The association of anti‐platelet factor 4/heparin antibodies with early and delayed thromboembolism after cardiac surgery
IJ Welsby, EF Krakow, JA Heit, EC Williams, GM Arepally, S Bar‐Yosef, ...
Journal of Thrombosis and Haemostasis 15 (1), 57-65, 2017
212017
Harnessing the power of alloreactivity without triggering graft-versus-host disease: how non-engrafting alloreactive cellular therapy might change the landscape of acute …
EF Krakow, J Bergeron, S Lachance, DC Roy, JS Delisle
Blood Reviews 28 (6), 249-261, 2014
162014
Azithromycin use and increased cancer risk among patients with bronchiolitis obliterans after hematopoietic cell transplantation
GS Cheng, L Bondeelle, T Gooley, Q He, K Jamani, EF Krakow, ...
Biology of Blood and Marrow Transplantation 26 (2), 392-400, 2020
142020
An acquired factor V inhibitor associated with defective factor V function, storage and binding to multimerin 1
SB Jeimy, EF Krakow, N Fuller, S Tasneem, CPM Hayward
Journal of Thrombosis and Haemostasis 6 (2), 395-397, 2008
142008
The challenges of informed consent in high-stakes, randomized oncology trials: a systematic review
JM Nathe, EF Krakow
MDM policy & practice 4 (1), 2381468319840322, 2019
122019
Do we need full donor chimerism? How alloreactive cell therapies without substantial engraftment might treat hematologic cancers
E F Krakow, HS Ai, B Shaffer, JS Delisle, KX Hu, A D Sung
Current Drug Targets 18 (3), 281-295, 2017
122017
Influence of sample collection and storage on the detection of platelet factor 4–heparin antibodies
EF Krakow, R Goudar, E Petzold, S Suvarna, M Last, IJ Welsby, TL Ortel, ...
American journal of clinical pathology 128 (1), 150-155, 2007
92007
Naive T-cell depletion to prevent chronic graft-versus-host disease
M Bleakley, A Sehgal, S Seropian, MA Biernacki, EF Krakow, A Dahlberg, ...
Journal of Clinical Oncology 40 (11), 1174-1185, 2022
82022
Ibrutinib monotherapy in relapsed or refractory, transformed diffuse large B-cell lymphoma
SA Graf, RD Cassaday, K Morris, JM Voutsinas, QV Wu, S Behnia, ...
Clinical Lymphoma Myeloma and Leukemia 21 (3), 176-181, 2021
52021
Microtransplantation Interest Group. HLA-mismatched microtransplant in older patients newly diagnosed with acute myeloid leukemia: results from the Microtransplantation …
M Guo, NJ Chao, JY Li, DA Rizzieri, QY Sun, A Mohrbacher, EF Krakow, ...
JAMA Oncol 4 (1), 54-62, 2018
52018
Phase I study of adoptive immunotherapy with HA-1-specific CD8+ and CD4+ memory T cells for children and adults with relapsed acute leukemia after allogeneic hematopoietic stem …
EF Krakow, C Summers, A Dahlberg, M Bar, MA Biernacki, T Cunningham, ...
Blood 136, 45-46, 2020
42020
Precision medicine: Statistical methods for estimating adaptive treatment strategies
EEM Moodie, EF Krakow
Bone Marrow Transplantation 55 (10), 1890-1896, 2020
42020
B-cell lymphoma unclassifiable with features intermediate between diffuse large B-cell lymphoma and Burkitt's lymphoma: Comparison study of clinical outcome and treatment response
M Sur, L Edwards, EF Krakow, VC Bhagirath, C Keng, A Lytwyn
J Clin Anat Pathol 2, 1-8, 2014
42014
Current state of nonengrafting donor leukocyte infusion (focus on microtransplantation for acute myeloid leukemia)
EF Krakow
Current Opinion in Hematology 26 (6), 373-378, 2019
32019
The system can't perform the operation now. Try again later.
Articles 1–20